Cargando…

Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality

BACKGROUND AND AIM: As the clinical course of metabolic‐associated fatty liver disease (MAFLD) is unclear, we compared the clinical courses of MAFLD and non‐alcoholic FLD (NAFLD). METHODS: Asian FLD patients (n = 987) from 1991 to 2021 (biopsy‐proven in 939) were enrolled. The patients were divided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogasawara, Yuri, Kogiso, Tomomi, Horiuchi, Kentaro, Taniai, Makiko, Tokushige, Katsutoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290268/ https://www.ncbi.nlm.nih.gov/pubmed/37359113 http://dx.doi.org/10.1002/jgh3.12898

Ejemplares similares

Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2023)

Long‐term outcome of Wilson's disease complicated by liver disease
por: Arai, Satoko, et al.
Publicado: (2021)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Long-term Follow-up of a Patient with Portal Hypertension and Hepatic Failure Due to Hepatic Hydatid Disease
por: Takenaka, Yuki, et al.
Publicado: (2021)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Bardet-Biedl Syndrome Caused by Skipping of SCLT1 Complicated by Microvesicular Steatohepatitis
por: Horiuchi, Kentaro, et al.
Publicado: (2020)

Risk factors for Fontan-associated hepatocellular carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2022)

Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer
por: Otsuka, Nao, et al.
Publicado: (2023)

Fontan-associated liver disease and hepatocellular carcinoma in adults
por: Kogiso, Tomomi, et al.
Publicado: (2020)

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
por: Tokushige, Katsutoshi, et al.
Publicado: (2013)

The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus
por: Ikarashi, Yuichi, et al.
Publicado: (2017)

The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2017)

Current Therapy and Liver Transplantation for Portopulmonary Hypertension in Japan
por: Tokushige, Katsutoshi, et al.
Publicado: (2023)

Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Atypical Sarcoidosis Diagnosed by Massive Splenomegaly
por: Saito, Satomi, et al.
Publicado: (2019)

Giant Hepatic Hemangioma Causing Prolonged Fever and Indicated for Resection
por: Yoshimizu, Chihiro, et al.
Publicado: (2021)

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease
por: Chishima, Sayaka, et al.
Publicado: (2017)

Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study
por: Kogiso, Tomomi, et al.
Publicado: (2017)

Characteristics of NAFLD Based on Hypopituitarism
por: Kodama, Kazuhisa, et al.
Publicado: (2020)

Elevated α-Fetoprotein in the Absence of Carcinoma Caused by Relapse of Hepatitis C Viral Infection after Liver Transplantation
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Successful Treatment of Ascites using a Denver(Ⓡ) Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome
por: Kogiso, Tomomi, et al.
Publicado: (2016)

Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates
por: Hayashi, Ryoko, et al.
Publicado: (2022)

Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis
por: Noto, Haruka, et al.
Publicado: (2014)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities
por: Wijarnpreecha, Karn, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
por: Sumida, Yoshio, et al.
Publicado: (2021)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
por: Yoneda, Masato, et al.
Publicado: (2017)

Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
por: Kotlyarov, Stanislav
Publicado: (2023)

Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
por: Jung, Han Na, et al.
Publicado: (2023)

Alcohol and hepatocarcinogenesis
por: Taniai, Makiko
Publicado: (2020)

Neurological and neuropsychiatric comorbidities occurring in fatty liver diseases
por: Balmus, I. M., et al.
Publicado: (2023)

Comorbidities and Outcomes among Females with Non-Alcoholic Fatty Liver Disease Compared to Males
por: Abu-Freha, Naim, et al.
Publicado: (2022)

Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease
por: Nagase, Yuka, et al.
Publicado: (2023)

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease
por: Cheng, Yuan-Lung, et al.
Publicado: (2017)

Characteristics, Outcomes, and Risk Factors for Upper Gastrointestinal Bleeding in Inpatients - A Comparison with Outpatients
por: Kobayashi, Ayako, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dgtc9uej01fun1crh32sbcrsim